These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 4836410)
1. Potential anticancer agents. 10. Synthesis of N-(4((2,4-diamino-7-pteridyl)methyl)-N10-methylamino)benzoyl)glutamic acid. Suster DC; Feyns VL; Ciustea G; Botez G; Dobre V; Bick R; Niculescu-Duvăz I J Med Chem; 1974 Jul; 17(7):758-60. PubMed ID: 4836410 [No Abstract] [Full Text] [Related]
2. Potential anticancer agents. 17. Analogues of methotrexate with a tripeptide side chain. Suster DC; Tărnăuceanu E; Botez G; Dobre V; Niculescu-Duvăz I J Med Chem; 1978 Nov; 21(11):1165-7. PubMed ID: 722723 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate analogs. 6. Replacement of glutamic acid by various amino acid esters and amines. Chaykovsky M; Brown BL; Modest EJ J Med Chem; 1975 Sep; 18(9):909-12. PubMed ID: 808614 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate analogs. 4.7-Methyl derivatives of methotrexate and dichloromethotrexate. A new synthesis and some biological studies. Rosowsky A; Chen KK J Med Chem; 1974 Dec; 17(12):1308-11. PubMed ID: 4214928 [No Abstract] [Full Text] [Related]
5. Potential anticancer agents. XXIII. 2. Quantitative structure--activity relationships (QSAR) in the "classical" antifolates area. Niculescu-Duvaz I; Craescu T Neoplasma; 1982; 29(1):53-63. PubMed ID: 7070555 [No Abstract] [Full Text] [Related]
6. Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain. Suster DC; Tărnăuceanu E; Ionescu D; Dobre V; Niculescu-Duvăz I J Med Chem; 1978 Nov; 21(11):1162-5. PubMed ID: 722722 [TBL] [Abstract][Full Text] [Related]
7. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity. Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730 [TBL] [Abstract][Full Text] [Related]
8. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors. Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407 [TBL] [Abstract][Full Text] [Related]
9. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid. Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690 [TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide. Complete inhibition of murine leukemia L1210 in vivo by a Fenton oxidation product. Struck RF; Thorpe MC; Coburn WC; Laster WR J Am Chem Soc; 1974 Jan; 96(1):313-5. PubMed ID: 4810573 [No Abstract] [Full Text] [Related]
11. Methotrexate analogues. 19. Replacement of the glutamate side chain in classical antifolates by L-homocysteic acid and L-cysteic acid: effect on enzyme inhibition and antitumor activity. Rosowsky A; Forsch RA; Freisheim JH; Moran RG; Wick M J Med Chem; 1984 May; 27(5):600-4. PubMed ID: 6546949 [TBL] [Abstract][Full Text] [Related]
12. Methotrexate analogs. 2. A facile method of preparation of lipophilic derivatives of methotrexate and 3',5'-dichloromethotrexate by direct esterification. Rosowsky A J Med Chem; 1973 Oct; 16(10):1190-3. PubMed ID: 4201424 [No Abstract] [Full Text] [Related]
13. Synthesis and pharmacological screening of 1-chloro-3-(2-propynyloxy)-2-propanols and 2-((2-propynyloxy)methyl)oxiranes. Fugitt RB; Wu GS; Martinelli LC J Pharm Sci; 1973 Nov; 62(11):1894-6. PubMed ID: 4758098 [No Abstract] [Full Text] [Related]
14. Folic acid analogs. II. p-[(2,6-Diamino-8-purinyl)methyl]amino-benzoyl-L-glutamic acid and related compounds. Weinstock LT; Grabowski BF; Cheng CC J Med Chem; 1970 Sep; 13(5):995-7. PubMed ID: 5458404 [No Abstract] [Full Text] [Related]
15. Synthesis and cytotoxic activity of pyranocoumarins of the seselin and xanthyletin series. Magiatis P; Melliou E; Skaltsounis AL; Mitaku S; Léonce S; Renard P; Pierré A; Atassi G J Nat Prod; 1998 Aug; 61(8):982-6. PubMed ID: 9722480 [TBL] [Abstract][Full Text] [Related]
16. Potential anticancer agents. XXIII. 1. Qualitative structure--activity relationship in the "classical" antifolates area. Niculescu-Duvaz I; Ciustea G; Stoicescu D; Muresan Z; Dobre V Neoplasma; 1982; 29(1):43-52. PubMed ID: 7070554 [TBL] [Abstract][Full Text] [Related]
17. Pyrimidine nucleosides. 5. Syntheses of carcinostatic halogenocyclonucleosides. Kanai T; Ichino M; Hoshi A; Kanzawa F; Kuretani K J Med Chem; 1972 Dec; 15(12):1218-21. PubMed ID: 4635963 [No Abstract] [Full Text] [Related]
18. Methotrexate analogues. 28. Synthesis and biological evaluation of new gamma-monoamides of aminopterin and methotrexate. Rosowsky A; Bader H; Radike-Smith M; Cucchi CA; Wick MM; Freisheim JH J Med Chem; 1986 Sep; 29(9):1703-9. PubMed ID: 3462394 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin. Johnston TP; McCaleb GS; Montgomery JA J Med Chem; 1975 Jan; 18(1):104-6. PubMed ID: 122802 [No Abstract] [Full Text] [Related]